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The American Society of Pediatric Hematology/Oncology Distinguished
Career Award Goes to Laurence A. Boxer, MD
Laurence A. Boxer, MD, this year’s recipient of the Distin-
guished Career Award from the American Society of Pediatric
Hematology/Oncology, is a leader in pediatric hematology/
oncology with a long career marked by accomplishment and
leadership in research, training, and patient care, as well as
exceptional service to ASPHO and other scientific societies.
Larry was born in Denver in 1940 to Sam and Tillie Boxer, the
eldest of their three boys. Sam and Tillie ran a mom and pop
plumbing operation, Belmont Plumbing, starting when Denver was
a relatively small town.
Larry attended East High School in Denver. His brother Mike
recalls, ‘‘The time was the ’50s and the school was right out of
‘American Graffiti.’ Larry was on student council and very popular
in school. He was accepted to attend Yale University, but took a
scholarship he was awarded to the University of Colorado,’’
graduating in 1961, magna cum laude in history.
Larry made many life long friends at Colorado and the Phi Sigma
Delta fraternity. His brother Mike writes, ‘‘Many of his fraternity
brothers still talk about how he kept kosher while living in the
fraternity house. It was widely believed that Larry was going to be a
Rabbi.’’ His father preferred that he enter the family business, but
told Larry ‘‘if you cannot become a plumber, you can always
become a doctor.’’ Larry chose the latter and attended Stanford
Medical School. Earlier this year, he was honored as the J. Wallace
Sterling Outstanding Medical Alumnus of Stanford University.
After receiving his M.D. from Stanford University in 1966, he
trained as a resident in pediatrics at Yale University from 1966 to
1968. There he met his wife, Grace, now a medical hematologist
with whom he has collaborated on several research studies and
publications. Their son David, born in 1976, is a teacher,
information technologist, and social activist.
He returned to Stanford as a senior resident, from 1969 to 1972
and served his Vietnam-era military duty as a pediatrician at the
Tripler Army Hospital in Honolulu, an experience that he fondly
recalls to have sparked a lifelong affinity for the Hawaiian Islands.
From 1972 to 1975 he was a fellow and then an instructor in
hematology at Children’s Hospital Boston, and Harvard Medical
School. In 1975, he was appointed Assistant Professor of Pediatrics
at Indiana University School of Medicine and became a Professor of
Pediatrics in 1982. That same year he moved to Ann Arbor,
Michigan where he assumed the position of Professor and Director
of the Division of Pediatric Hematology/Oncology at the University
of Michigan, where he has also served as Associate Chair for
Research and subsequently for Faculty Affairs. In 2003 he was
named to the Henry and Mala Dorfman Family Chair in Pediatric
Hematology/Oncology, a Professorship established in part to
recognize the extraordinary care provided by Larry to two of the
Dorfman children. Larry has just retired as director of the pediatric
hematology/oncology division, but will continue his considerable
efforts in research, teaching, and patient care.
Larry has received national and international recognition for his
success as a physician-scientist, clinician, and teacher. He has
served as a councilor of the Society for Pediatric Research (1982–
1985), the American Society of Hematology (1988–1992) and the
American Pediatric Society (2001–2006), and was elected
president of the Society for Pediatric Research (1985–1986). His
research accomplishments have been recognized with the Pediatric
Academic Societies’ highest recognition for research, the Mead
Johnson Award (1983). In 1997, Larry was elected a fellow of the
American Association for the Advancement of Science and in 1998,
he received the Founder’s Award from the Midwest Society for
Pediatric Research. Larry has also been elected to the American
Society of Clinical Investigation and the American Association of
Physicians, and serves as a founding section editor for HEM/ONC
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TODAY—these particular honors indicate the esteem with which he is
regarded by our colleagues in internal medicine and medical
oncology.
Larry has worked in many other editorial positions, including
associate editor for the Journal of Clinical Investigation and the
American Journal of Hematology. He has served on multiple
editorial boards – including, at the present time, Current Opinion in
Hematology, Hematotherapy and Stem Cell Research, Pediatrics in
Review, Pediatric Blood and Cancer, and American Journal of
Hematology—and is currently a member of the ASH Publications
Committee.
In ASPHO, Larry currently serves as a trustee and member of the
Executive Board. As a member and then chair of the Publications
Committee, he played an instrumental role in the establishment of
this journal. Larry also helped organize and teach the highly
successful board review course.
Larry’s research has focused on disorders of phagocyte number
and function. His laboratory research has received continuous
support by the National Institutes of Health since 1976. His
contributions include major discoveries in the pathology, molecular
biology, and treatment of phagocyte disorders including Chédiak–
Higashi syndrome, secondary granule deficiency, and chronic
granulomatous disease, as well as fundamental investigations into
the biochemistry of neutrophil phagocytosis, granule sorting, and
exocytosis. His clinical research in neutropenia included important
clinical trials of G-CSF for congenital neutropenia and, through his
leadership role in the Severe Chronic Neutropenia International
Registry, influential and ongoing investigations of the molecular
basis of congenital neutropenia and the risks of myelodysplasia and
AML in G-CSF-treated patients.
Although Larry did not follow his early inclination to be a rabbi,
he definitely became a teacher. Junior faculty members and fellows
(over 35 to date) who have trained or established their early careers
under Dr. Boxer’s mentorship now lead major academic programs,
are corporate officers in pharmaceutical giants, or deliver world-
class care in clinical programs and major academic medical centers.
Several have become division directors or hold endowed chairs, one
heads a research division within the NIH, and one chairs a
department of pediatrics. Importantly, he is a strong advocate for
encouraging trainees to develop careers in benign hematology—a
field that certainly can use more practitioners. Larry has lectured
nationally and internationally, including invitations to endowed
lectureships at leading universities in the United States, Canada, The
Netherlands, and Israel. Locally, in 2005 he was selected as one of
the outstanding teachers for the house staff in the Department of
Pediatrics at the University of Michigan.
Larry’s expertise and compassion in patient care have led to his
citation in The Best Doctors in America since 1994. Patients and
families seek his advice, particularly in the management of
neutropenia, from throughout the nation and the world. In addition
to his fundamental clinical research on the efficacy of G-CSF in the
treatment of severe chronic neutropenia, he was an early and
effective advocate in encouraging Amgen Pharmaceuticals to
provide the drug at no cost for patients in the International Registry.
Larry has been a speaker at family support groups for neutropenia
for many years and hosted the annual neutropenia family meeting in
Ann Arbor this past July. He has also advocated for young adults’
access to cancer clinical trials and for manpower to care for children
with benign hematological disorders.
Larry’s extraordinary record of achievement and commitment to
our discipline and to ASPHO are matched by his incredibly warm,
engaging and friendly demeanor that is cherished by all who have
had the pleasure to work with him over the years. Certainly
‘‘distinguished career’’ most appropriately describes his contribu-
tions to the field of pediatric hematology/oncology and to his many
patients, colleagues, and students.
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